Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine

BACKGROUND: Gait impairment is common in multiple sclerosis (MS) and negatively impacts patients’ health-related quality of life (HRQoL). Prolonged-release fampridine (PR-fam) improves walking speed, but it is unclear which walking measures are the most suitable for identifying treatment response. O...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Neurol Disord
Asıl Yazarlar: Sola-Valls, Núria, Blanco, Yolanda, Sepúlveda, María, Llufriu, Sara, Martínez-Lapiscina, Elena H., Zubizarreta, Irati, Pulido-Valdeolivas, Irene, Montejo, Carmen, Villoslada, Pablo, Saiz, Albert
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2018
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6024337/
https://ncbi.nlm.nih.gov/pubmed/29977342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756286418780007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller